3,4-methylenedioxyamphetamine has been researched along with Hearing Loss in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, BB | 1 |
| Wu, J | 1 |
| Chen, J | 1 |
| Chen, H | 1 |
| Li, YH | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Hearing Loss
| Article | Year |
|---|---|
[Protective effect of peperphentonamine injection through the otocyst against gentamicin- induced cochlear damage in guinea pigs].
Topics: 3,4-Methylenedioxyamphetamine; Animals; Apoptosis Regulatory Proteins; Beclin-1; Cochlea; Endothelin | 2016 |